Skip Navigation National Cancer Institute U.S. National Institutes of Health www.cancer.gov
 

Fighting HIV/AIDS and HIV Malignancies through...

HIV/AIDS and HIV Malignancy Research in the NCI:

The NCI has played a major role in HIV/AIDS research since the beginning of the epidemic, when a cluster of cases of Kaposiís sarcoma was one of the harbingers of this new disease. NCI scientists have made a number of key discoveries in both HIV/AIDS and AIDS-associated cancer. Today, this research is carried out in multiple Divisions and Offices of the NCI.   |   Learn More

OHAMís Role:

OHAM is responsible for coordinating and overseeing HIV/AIDS research throughout the NCI. In addition, it directly oversees a number of programs in AIDS-related cancer as well as HIV/AIDS.   |   Learn More

   Spotlight

New immunotherapy trial for HIV-positive cancer patients

NIH develops new priorities and guidelines to determine AIDS funding beginning in FY 2016. These guidelines will be used to prioritize HIV/AIDS Research projects to determine which are eligible for AIDS-designated funds. Details can be found in NOT-OD-15-137.

Learn more about the new NCI-supported clinical trial, Anal Cancer HSIL Outcomes Research (ANCHOR) Study





   Funding Opportunities View All    News and Events
New FOAs
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers
View All

CROI 2017: Seattle
February 13-16, 2017
Washington State Convention Center
Seattle, Washington

HPV 2017
February 28 – March 4, 2017
Cape Town, South Africa

16th International Conference on Malignancies in HIV/AIDS (aka ICMAOI)
Fall of 2017
Dates to follow

NCI investigators test pomalidomide as a possible new treatment for Kaposi sarcoma

HIV-related cancer research highlights from CROI

Excess cancer incidence in HIV-positive people.

HIV-Positive Patients with Lymphoma should be eligible for Stem Cell Transplants.

NCIís investigators Hughes and colleagues describe a new paradigm in HIV reservoir research